116 related articles for article (PubMed ID: 22426480)
1. Androgen receptor is up-regulated by a BLT2-linked pathway to contribute to prostate cancer progression.
Lee JW; Kim GY; Kim JH
Biochem Biophys Res Commun; 2012 Apr; 420(2):428-33. PubMed ID: 22426480
[TBL] [Abstract][Full Text] [Related]
2. BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway.
Kim EY; Seo JM; Kim C; Lee JE; Lee KM; Kim JH
Free Radic Biol Med; 2010 Sep; 49(6):1072-81. PubMed ID: 20600831
[TBL] [Abstract][Full Text] [Related]
3. Pro-survival of estrogen receptor-negative breast cancer cells is regulated by a BLT2-reactive oxygen species-linked signaling pathway.
Choi JA; Lee JW; Kim H; Kim EY; Seo JM; Ko J; Kim JH
Carcinogenesis; 2010 Apr; 31(4):543-51. PubMed ID: 19748928
[TBL] [Abstract][Full Text] [Related]
4. Activation of the leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS) cascade following detachment confers anoikis resistance in prostate cancer cells.
Lee JW; Kim JH
J Biol Chem; 2013 Oct; 288(42):30054-30063. PubMed ID: 23986446
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis.
Kim GY; Lee JW; Ryu HC; Wei JD; Seong CM; Kim JH
J Immunol; 2010 Apr; 184(7):3946-54. PubMed ID: 20194723
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.
Wang LG; Ossowski L; Ferrari AC
Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species are generated through a BLT2-linked cascade in Ras-transformed cells.
Choi JA; Kim EY; Song H; Kim C; Kim JH
Free Radic Biol Med; 2008 Feb; 44(4):624-34. PubMed ID: 18082638
[TBL] [Abstract][Full Text] [Related]
8. Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway.
Kim EY; Seo JM; Cho KJ; Kim JH
Oncogene; 2010 Feb; 29(8):1167-78. PubMed ID: 19935719
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
12. Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor.
Cho KJ; Seo JM; Shin Y; Yoo MH; Park CS; Lee SH; Chang YS; Cho SH; Kim JH
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):294-303. PubMed ID: 19448154
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of prostate cancer cell survival after inhibition of AR expression.
Cohen MB; Rokhlin OW
J Cell Biochem; 2009 Feb; 106(3):363-71. PubMed ID: 19115258
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
17. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM; Frazier MC; Harris WB
Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
[TBL] [Abstract][Full Text] [Related]
18. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
20. The role of the androgen receptor in the development and progression of prostate cancer.
Jenster G
Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
